This is only for current weight loss clients being to transitioned to Tirzepatide.

Tirzepatide is unique in that it targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, which work together to improve insulin sensitivity and reduce appetite, making it more effective than many other weight loss medications. By suppressing hunger and cravings, Tirzepatide can make it easier for patients to reduce caloric intake and follow a healthier diet, supporting sustainable weight management. In addition, Tirzepatide has been shown to promote significant weight loss by regulating appetite and controlling blood sugar, helping patients achieve their weight loss goals.